Table 3.
Participants taking anti-diabetic drugs
| Count | mp_med |
|---|---|
| 1 | Insulin glargine |
| 3 | Glimepiride |
| 46 | Metformin |
| 4 | Rosiglitazone |
| 2 | Glipizide |
| 17 | Gliclazide |
| 4 | Pioglitazone |
| 1 | Sitagliptin |
Participants taking anti-diabetic drugs
| Count | mp_med |
|---|---|
| 1 | Insulin glargine |
| 3 | Glimepiride |
| 46 | Metformin |
| 4 | Rosiglitazone |
| 2 | Glipizide |
| 17 | Gliclazide |
| 4 | Pioglitazone |
| 1 | Sitagliptin |